MeSH D017180 - ventricular tachycardia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Epinephrine | Medihaler-epi |  | 1982-01-01 |  |  |
| A.H. Robins Company | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Lidocaine | Lidocaine |  | 1983-02-02 |  |  |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| Lidocaine | Lta |  | 1984-07-31 |  |  | |
| Accord Healthcare | Metoprolol | Metoprolol |  | 2022-10-18 |  |  |
| Adamis Pharmaceuticals | Epinephrine | Symjepi | 2036-10-20 | 2017-06-15 |  |  |
| Afaxys | Lidocaine | Lidocaine |  | 2022-06-09 |  |  |
| Alembic Pharmaceuticals | Metoprolol | Metoprolol |  | 2013-05-28 |  |  |
| Hydrochlorothiazide, Metoprolol | Metoprolol Hydrochlorothiazide |  | 2013-11-06 |  |  | |
| Lidocaine | Lidocaine |  | 2018-11-23 |  |  | |
| Lidocaine, Prilocaine | Lidocaine Prilocaine |  | 2022-04-08 |  |  | |
| Alkem Laboratories | Lidocaine | Lidocaine |  | 2017-03-10 |  |  |
| Metoprolol | Metoprolol |  | 2020-11-25 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
71%10/14
Phase 3
69%20/29
Approved: 13Overall Success rate: 49%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use